AMED News Alert Amedisys Inc (AMED) 25.09 11/13/2014 16:19:5

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 5:19 PM

Amedisys Inc (AMED) 25.09 $AMED

Uptrend Call Working As Amedisys Stock Rises 56.1% (AMED)
Comtex SmarTrend(R) - Tue Nov 11, 10:58AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 5 months, Amedisys has returned 56.08% as of today's recent price of $24.98.
AMED: 25.09 (-0.02)

Earnings Look Back: Amedisys Is Down 1.7% Since Reporting Quarterly Results 1 Week Ago (AMED)
Comtex SmarTrend(R) - Mon Nov 10, 11:50AM CST
A week ago on October 29th, 2014 Amedisys (NASDAQ:AMED) reported earnings and analysts, on average, expected earnings of $0.15 on sales of $299.2 million. The company actually reported EPS of $0.28 on sales of $300.3 million, beating EPS estimates by $0.13 and beating revenue estimates by $1.1 million. Shares of Amedisys have slipped from $25.22 to $24.79, representing a loss of 1.7%, since the company reported earnings 12 days ago.
AMED: 25.09 (-0.02)

Amsurg's Q3 Earnings Top on Revenue Growth, View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:20AM CST
Amsurg Corp. (AMSG) reported third-quarter 2014 adjusted earnings per share (EPS) of 66 cents from continuing operations.
CHE: 107.88 (-2.12), AMSG: 50.26 (-0.16), RDNT: 8.30 (-0.05), AMED: 25.09 (-0.02)

2014 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide
GlobeNewswire - Wed Nov 05, 10:00AM CST
Amedisys, a leading healthcare at home company (Nasdaq:AMED), today announced that 162 of its care centers across the country have been named to the 2014 HomeCare Elite(TM), a compilation of the top-performing home health agencies in the United States compiled annually by OCS Home Care and DecisionHealth.
NRCIA: 17.97 (+0.02), AMED: 25.09 (-0.02), NRCIB: 34.14 (-0.10)

Can Amedisys (AMED) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:50AM CST
Amedisys could be an interesting play for investors as the stock has a decent short-term momentum and is seeing solid activity on the earnings estimate revision
AMED: 25.09 (-0.02)

Amedisys Up 61.4% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Tue Nov 04, 9:40AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 61.39% as of today's recent price of $25.83.
AMED: 25.09 (-0.02)

Your Best Stocks Will Be in the Best Industries - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 04, 3:01AM CST
Your Best Stocks Will Be in the Best Industries - Screen of the Week
BCC: 37.19 (-0.01), HNI: 46.78 (-1.17), ALDW: 17.59 (-1.28), AMED: 25.09 (-0.02), FLWS: 9.01 (-0.02)

Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 12.06 (+0.79), EMR: 63.52 (-0.53), AMED: 25.09 (-0.02), AAPL: 112.82 (+1.57)

Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 50.26 (-0.16), USPH: 39.36 (-0.34), RDNT: 8.30 (-0.05), AMED: 25.09 (-0.02)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.87 (unch), ACMP: 61.72 (-0.02), AMAG: 34.24 (-0.69), AMED: 25.09 (-0.02), ACCO: 8.80 (-0.06)

Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 25.09 (-0.02)

Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 35.97 (+5.30), ABMD: 33.48 (-0.12), BGFV: 13.32 (-0.06), RDCM: 9.34 (+0.04), AMED: 25.09 (-0.02), MRCY: 13.41 (-0.22), OMER: 19.57 (-0.14), ESBF: 18.78 (-0.49), EVOK: 6.40 (+0.10), IQNT: 18.51 (-0.11), KONA: 22.85 (-0.16), TQNT: 22.17 (+0.07), LAKE: 11.39 (-0.85), SAJA: 6.21 (+0.31)

Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 50.75 (+0.24), ZLTQ: 26.77 (-0.63), EA: 41.44 (+0.24), AMED: 25.09 (-0.02)

Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 26.42 (-0.10), SCTY: 50.84 (-1.21), JCP: 7.10 (-0.66), AMED: 25.09 (-0.02), RFMD: 13.33 (+0.08)

Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 50.26 (-0.16), USPH: 39.36 (-0.34), RDNT: 8.30 (-0.05), AMED: 25.09 (-0.02)

Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 25.09 (-0.02)

Amedisys' (AMED) CEO Ronald LaBorde on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 12:50PM CDT

AMED: 25.09 (-0.02)

Amedisys ups earnings 109% in Q3
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 12:23PM CDT

AMED: 25.09 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...